GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
W

Wanbury WANBURY.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

200.71

+0.83%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹6.50bn

FY2017FY2026

Net income

₹661.3m

FY2017FY2026

Free cash flow

−₹568.4m

FY2017FY2026

Shareholders' equity

₹1.44bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₹6.50bn₹6.00bn₹5.74bn₹4.98bn₹5.11bn₹3.87bn₹3.63bn₹3.87bn₹3.68bn₹4.29bn
Research and development—————₹35.1m₹42.5m₹88.4m₹123.1m—
Operating income₹924.4m₹630.0m₹572.1m₹118.6m₹1.02bn₹147.3m₹975.4m₹66.5m−₹93.8m₹979.1m
Net income₹661.3m₹305.3m₹559.6m−₹104.0m₹814.7m−₹126.1m₹644.6m−₹248.5m−₹320.1m₹620.1m
Diluted earnings per share18.938.7416.08-3.1724.86-4.0425.74-10.52-13.5217.75

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₹5.18bn₹4.14bn₹3.43bn₹3.04bn₹3.53bn₹2.89bn₹2.79bn₹2.86bn₹2.73bn₹4.12bn
Cash and short-term investments₹76.3m₹150.6m₹34.0m₹14.9m₹226.6m₹101.3m₹147.0m₹27.4m₹28.7m₹50.3m
Total liabilities₹3.73bn₹3.55bn₹3.16bn₹3.36bn₹3.76bn₹4.45bn₹4.22bn₹4.95bn₹4.57bn₹5.65bn
Debt₹2.24bn₹1.77bn₹1.16bn₹1.09bn₹1.08bn₹2.04bn₹2.08bn₹2.88bn₹2.79bn₹3.29bn
Shareholders' equity₹1.44bn₹592.7m₹279.4m−₹61.5m−₹234.2m−₹1.56bn−₹1.43bn−₹2.09bn−₹1.85bn−₹1.53bn
Shares outstanding35m35m35m33m33m31m25m24m24m35m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations₹27.8m₹261.0m₹39.8m₹198.0m₹405.2m₹166.8m₹441.3m₹297.3m₹323.6m₹433.9m
Capital spending−₹596.1m−₹490.3m−₹174.2m−₹126.3m−₹96.6m−₹44.3m−₹78.3m−₹47.2m−₹28.4m−₹147.0m
Free cash flow−₹568.4m−₹229.3m−₹134.5m₹71.7m₹308.7m₹122.5m₹363.0m₹250.2m₹295.2m₹286.8m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹1.66bn₹1.65bn₹1.62bn₹1.60bn₹1.63bn₹1.72bn₹1.33bn₹1.61bn
Operating income₹122.0m₹266.2m₹229.5m₹220.8m₹208.0m₹262.5m₹114.6m₹183.2m
Net income₹32.4m₹217.0m₹157.6m₹151.8m₹134.9m₹202.6m₹12.2m₹80.2m
Diluted earnings per share0.936.214.514.343.865.800.352.30
Cash from operations———−₹56.0m—₹261.0m—−₹185.0m
Capital spending———−₹191.0m—−₹490.0m—−₹234.0m
Free cash flow———−₹247.0m—−₹229.0m—−₹419.0m
Total assets—₹5.18bn—₹4.57bn—₹4.14bn—₹3.97bn
Cash and short-term investments₹76.3m₹76.3m₹105.0m₹131.6m₹129.6m₹150.6m₹117.5m₹137.6m
Debt—₹2.22bn—₹1.96bn—₹1.77bn—₹1.81bn
Shareholders' equity₹1.44bn₹1.44bn₹1.07bn₹1.07bn₹592.7m₹592.7m₹387.5m₹387.5m

Financial ratios

Data as of 7 Oct 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2007FY2006
Operating margin13.8%11.1%14.9%2.2%19.9%2.8%—————
Net margin10.2%5.1%9.7%-2.1%15.9%-3.3%—————
Return on equity45.8%51.5%200.3%168.9%-347.9%8.1%—————
Return on assets12.8%7.4%16.3%-3.4%23.1%-4.4%—————
Free cash flow yield9.0%10.8%3.1%5.0%7.7%3.4%—————
Revenue growth8.5%4.4%15.3%-2.5%32.1%6.8%—————
Earnings growth116.6%-45.4%-638.3%-112.8%-746.3%-119.6%—————
Current ratio1.19x1.11x0.74x0.39x0.48x0.28x—————
Debt to equity1.54x2.97x4.03x-17.26x-4.42x-1.28x—————
Equity ratio27.9%14.3%8.1%-2.0%-6.6%-54.0%—————
Interest coverage3.00x1.80x2.93x0.52x4.94x0.46x—————
R&D as a share of sales—————0.9%1.2%2.3%3.3%2.8%2.8%
Buybacks as a share of market value0.0%-0.4%-6.0%-0.2%-5.1%-24.6%—————

Growth per year

Compound annual rate

3 years5 years10 years
Revenue9.3%10.9%4.4%
Operating income98.3%44.4%14.3%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin12.4%9.7%10.6%10.8%
Net margin7.7%6.1%6.6%5.3%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings10.226.117.9-39.82.0-20.61.8-1.8-1.52.5
Price to sales1.01.31.80.80.30.70.30.10.10.4

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 29 Jul 2010.

FY2011FY2009
Paid in the year1.000.50

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.